Study of Adaptable Patients with type V dialyzer by the Nutrition index.

Study of Adaptable Patients with type V dialyzer by the Nutrition index. - Study of Adaptable Patients with type V dialyzer by the Nutrition index.(APEAN-STUDY)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006439

Enrollment

1000

Registered

2011-09-29

Start date

2011-09-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

Hemodialysis using APS-EA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All content are requested in the following. 1.Hemodialysis vintage more than one year 2.serum creatinine's value more than 6.0 mg/mL 3.serum albumin's value more than 3.0 g/dL 4.BMI more than 18 5.nothing more than NYHA 3 degree as clinical judge 6.without dementia 7.received informed consent and signed agreement sheet before study

Exclusion criteria

Exclusion criteria: Either content is full in the following 1.in treating with adsorption column for beta2-microglobrin 2.medical doctor assigned to be ineligible

Design outcomes

Primary

Measure	Time frame
Serum albumin (pre-dialysis)	—

Secondary

Measure	Time frame
Secondary endpoint-1:for all patients Serum creatinine, blood test, body weight, UN, BMI, serum iron, serum CRP, dialysate's name, dialsate's endtoxin, ESA's dosage, ultrafiltration volume Secondary endpoint-2:for parts of patients Serum transferrin, TIBC, serum ferritin, iron dosage, anti-hypertension agents' dosage, bacteria, beta2-microgroburin, alpha1-microgroburin	—

Countries

Japan

Contacts

Public ContactMasaki Nagasawa

APEAN-STUDY Group Japan Culture and Welfare Federation of Agricultural Cooperatives APEAN STUDY Group

sgh_cle@grn.janis.or.jp03-3370-2597

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026